(Q46488708)

22 December 2017

title

Long-term oral lacosamide in painful diabetic neuropathy: a two-year open-label extension trial (English)

1 reference

22 December 2017

1 reference

Aziz Shaibani

1

1 reference

22 December 2017

Victor Biton

2

1 reference

22 December 2017

Richard Rauck

3

1 reference

22 December 2017

Brigitte Koch

4

1 reference

22 December 2017

Jeffrey Simpson

5

1 reference

22 December 2017

publication date

10 July 2008

1 reference

22 December 2017

published in

European Journal of Pain

1 reference

22 December 2017

volume

13

1 reference

22 December 2017

issue

5

1 reference

22 December 2017

page(s)

458-463

1 reference

22 December 2017

EFNS guidelines on pharmacological treatment of neuropathic pain.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.05.016

Weight issues for people with epilepsy--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.05.016

Lacosamide: a review of preclinical properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.05.016

Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.05.016

Progress report on new antiepileptic drugs: a summary of the Eigth Eilat Conference (EILAT VIII)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.05.016

Diabetic neuropathies: a statement by the American Diabetes Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.05.016

Emerging therapies for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.05.016

Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.05.016

Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.05.016

New perspectives on the management of diabetic peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.05.016

Does SPM 927 have an analgesic effect in human neuropathic pain? An open label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.05.016

Long-term use of gabapentin for treatment of pain after traumatic spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.05.016

Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.05.016

Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.05.016

Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.05.016

CLINICAL REVIEW: Use of antiepileptic drugs in the treatment of chronic painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.05.016

Effects of treatments for symptoms of painful diabetic neuropathy: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.05.016

10.1016/J.EJPAIN.2008.05.016

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

release_kkv5ipgqobgvdefnrnvpcu6lmq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kkv5ipgqobgvdefnrnvpcu6lmq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

22 December 2017